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Abstract
Legionella pneumophila is a gram-negative bacterial pathogen that replicates in host macrophages and causes a severe
pneumonia called Legionnaires’ Disease. The innate immune response to L. pneumophila remains poorly understood. Here
we focused on identifying host and bacterial factors involved in the production of type I interferons (IFN) in response to L.
pneumophila. It was previously suggested that the delivery of L. pneumophila DNA to the host cell cytosol is the primary
signal that induces the type I IFN response. However, our data are not easily reconciled with this model. We provide genetic
evidence that two RNA-sensing proteins, RIG-I and MDA5, participate in the IFN response to L. pneumophila. Importantly,
these sensors do not seem to be required for the IFN response to L. pneumophila DNA, whereas we found that RIG-I was
required for the response to L. pneumophila RNA. Thus, we hypothesize that bacterial RNA, or perhaps an induced host RNA,
is the primary stimulus inducing the IFN response to L. pneumophila. Our study also identified a secreted effector protein,
SdhA, as a key suppressor of the IFN response to L. pneumophila. Although viral suppressors of cytosolic RNA-sensing
pathways have been previously identified, analogous bacterial factors have not been described. Thus, our results provide
new insights into the molecular mechanisms by which an intracellular bacterial pathogen activates and also represses
innate immune responses.
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Introduction
The intracellular bacterium Legionella pneumophila has become a
valuable model for the study of immunosurveillance pathways. L.
pneumophila is a motile gram-negative bacterium that is the cause of a
severe pneumonia called Legionnaires’ Disease [1]. In the
environment, L. pneumophila is believed to replicate in various
species of freshwater amoebae. In humans, L. pneumophila causes
disease by replicating within alveolar macrophages in the lung [2].
Replication in macrophages and amoebae requires a type IV
secretion system that the bacterium uses to inject effector proteins
into the host cell cytosol [3]. These effectors are believed to
orchestrate the creation of an intracellular vacuole in which L.
pneumophila can replicate. Interestingly, there appears to be
considerable redundancy among the effectors, and there are few
examples of single effector mutations that have a large effect on
intracellular replication of L. pneumophila. One L. pneumophila effector
required for intracellular replication is SdhA [4], but the mechanism
by which SdhA acts on host cells remains uncertain [4].
A variety of immunosurveillance pathways that detect L.
pneumophila infection have been described [5,6,7,8]. The best
characterized cytosolic immunosurveillance pathway requires the
host proteins Naip5 and Ipaf to detect the cytosolic presence of L.
pneumophila flagellin, leading to activation of caspase-1, rapid
pyroptotic macrophage death, and efficient restriction of bacterial
replication [9,10,11,12,13]. L. pneumophila has also been observed to
induce transcriptional activation of type I interferon (IFN) genes in
macrophages and epithelial-like cell lines by a mechanism that
remains incompletely characterized [14,15]. Induction of type I
IFNs by L. pneumophila is independent of the flagellin-sensing pathway
[16], but also appears to contribute to restriction of bacterial
replication in macrophages [16,17] and epithelial-like cell lines [14].
Type I IFNs are an important class of cytokines that orchestrate
diverse immune responses to pathogens [18]. Encoded by a single
IFNb gene as well as multiple IFNa and other (e.g., IFNe, k, d, f)
genes, type I IFNs are transcriptionally induced by a number of
immunosurveillance pathways, including Toll-like receptors (TLRs)
and a variety of cytosolic sensors [19]. For example, cytosolic RNA
is recognized by two distinct helicase and CARD-containing
sensors, RIG-I and MDA5 [20], that signal through the adaptor
IPS-1 (also called MAVS, CARDIF, or VISA) [21,22,23,24,25].
The cytosolic presence of DNA also induces type I IFNs, but this
phenomenon is less well understood [15,26]. Studies with Ips-1-
deficient mice have indicated that cytosolic DNA can signal
independently of Ips-1 in many cell types, including macrophages
[25]. However, cytosolic responses to DNA appear to require IPS-1
in certain cell types, including 293T cells [26,27]. Indeed, two
recent reports have described a pathway by which AT-rich DNA
can signal via IPS-1 [28,29]. In this pathway, DNA is transcribed by
RNA polymerase III to form an RNA intermediate that can be
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sensed by RIG-I. The RNA Pol III pathway appears to be
operational in macrophages, but is redundant with other DNA-
sensing pathways in these cells. A couple of reports have proposed
that DAI (also called ZBP-1) is a cytosolic DNA-sensor [30,31], but
Zbp1-deficient mice appear to respond normally to cytosolic DNA
[32], consistent with the existence of multiple cytosolic sensors for
DNA. Other small molecule compounds, such as cyclic-di-GMP
and DMXAA, can also trigger cytosolic immunosurveillance
pathways leading to induction of type I IFNs, but these remain to
be fully characterized [33,34,35].
Type I IFNs are typically considered antiviral cytokines that act
locally to induce an antiviral state and systemically to induce cellular
innate and adaptive immune responses [19]. Mice deficient in the
type I IFN receptor (Ifnar) are unable to respond to type I IFNs, and
are highly susceptible to viral infections. Interestingly, most bac-
terial infections also trigger production of type I IFNs, but the
physiological significance of type I IFNs in immune defense against
bacteria is complex. Type I IFN appears to protect against infection
with group B Streptococcus [36], but this is not the case for many other
bacterial infections. For example, the intracellular gram-positive
bacterium Listeria monocytogenes induces a potent type I IFN response
[37,38], but Ifnar-deficient mice are actually more resistant to L.
monocytogenes infection than are wildtype mice [39,40,41]. Many
bacterial pathogens, including Francisella tularensis, Mycobacterium
tuberculosis, Brucella abortus, and group B Streptococcus, induce type I
IFN production by macrophages via a cytosolic TLR-independent
pathway [42,43,44,45], but the bacterial ligands and host sensors
required for the interferon response of macrophages to these
bacteria remain unknown.
It was demonstrated that induction of type I IFN by L.
pneumophila in macrophages did not require bacterial replication or
signaling through the TLR-adaptors MyD88 or Trif, but did
require the bacterial Dot/Icm type IV secretion system [15].
Because the IFN response could be recapitulated with transfected
DNA [15,26] and because Dot/Icm system has been shown to
conjugate DNA plasmids to recipient bacteria [46], it was
proposed that perhaps L. pneumophila induced type I IFN via a
cytosolic DNA-sensing pathway [15]. Another report used RNA
interference to implicate the signaling adaptor IPS-1 (MAVS) in
the IFN response to L. pneumophila in human A549 epithelial-like
cells [14]. However, the significance of this latter finding is unclear
since RNAi-mediated knockdown of RIG-I and MDA5, the two
sensor proteins directly upstream of IPS-1, did not have an effect
on induction of type I IFN by L. pneumophila [14]. Moreover, the
A549 response to L. pneumophila may be distinct from the
macrophage or in vivo response.
Recently, one report proposed that L. pneumophila DNA was
recognized in the cytosol by RNA polymerase III [29], resulting in
the production of an RNA intermediate that triggered IFN
production via the IPS-1 pathway. Apparently consistent with this
proposal, Ips-1-deficient mouse macrophages did not produce type
I IFN in response to L. pneumophila [29]. Moreover, since Pol III
acts preferentially on AT-rich substrates, it is plausible that Pol III
would recognize the L. pneumophila genome, which has a high
proportion (62%) of A:T basepairs. However, the response to L.
pneumophila DNA was not investigated [29]. In addition, the same
report, as well as others [28,34], observed that the type I IFN
response to AT-rich (or any other) DNA is not Ips-1-dependent in
mouse cells. Thus, if L. pneumophila DNA was reaching the cytosol,
the simplest prediction would be that the resulting type I IFN
response would be independent of Ips-1, instead of Ips-1-
dependent, as was shown [29]. Thus, the mechanism of IFN
induction by L. pneumophila remains unclear.
In the present study, we sought to define bacterial and host
factors controlling the macrophage type I IFN response to L.
pneumophila. In agreement with previous studies [14,29], we find
that Ips-1 is required for optimal induction of type I IFN in
response to L. pneumophila infection in vitro. We extend this
observation by demonstrating that Ips-1 also contributes to the
type I IFN response in an in vivo model of Legionnaires’ Disease.
Furthermore, we provide the first evidence that two RNA sensors
upstream of Ips-1, Rig-i and Mda5, are involved in the macrophage
interferon response to L. pneumophila. Importantly, however, we did
not observe a role for the Pol III pathway in the type I IFN
response to L. pneumophila. Instead, we found that L. pneumophila
genomic DNA stimulates an Ips-1/Mda5/Rig-i-independent IFN
response in macrophages, which contrasts with the Ips-1-
dependent response to L. pneumophila infection. On the other
hand, we found that L. pneumophila RNA stimulated a Rig-i-
dependent IFN response. Thus, our data are consistent with a
model in which L. pneumophila RNA, or host RNA, rather than L.
pneumophila DNA, is the primary ligand that stimulates the host
IFN response. We also investigated whether bacterial factors that
modulate the host type I IFN response. Although numerous viral
proteins that interfere with IFN signaling have been described
[19], similar bacterial proteins have not been documented. It is
therefore interesting that we were able to identify a secreted
bacterial effector, SdhA, as an inhibitor of the Ips-1-dependent
IFN response to L. pneumophila. Taken together, our findings
provide surprising evidence that cytosolic RNA-sensing pathways
are not specific for viral infections but can also respond to bacterial
infections, and moreover, our data provide a specific example of a
bacterial factor that suppresses the host IFN response.
Results
The cytosolic RNA-sensing pathway is involved in the
macrophage response to L. pneumophila
We hypothesized that a cytosolic innate immune sensing
pathway controls the type I IFN response to L. pneumophila. To
Author Summary
Initial detection of invading microorganisms is one of the
primary tasks of the innate immune system. However, the
molecular mechanisms by which pathogens are recog-
nized remain incompletely understood. Here, we provide
evidence that an immunosurveillance pathway (called the
RIG-I/MDA5 pathway), thought primarily to detect viruses,
is also involved in the innate immune response to an
intracellular bacterial pathogen, Legionella pneumophila. In
the response to viruses, the RIG-I/MDA5 immunosurveil-
lance pathway has been shown to respond to viral RNA or
DNA. We found that the RIG-I pathway was required for
the response to L. pneumophila RNA, but was not required
for the response to L. pneumophila DNA. Thus, one
explanation of our results is that L. pneumophila RNA
may access the host cell cytosol, where it triggers the RIG-
I/MDA5 pathway. This is unexpected since bacteria have
not previously been thought to translocate RNA into host
cells. We also found that L. pneumophila encodes a
secreted bacterial protein, SdhA, which suppresses the
RIG-I/MDA5 pathway. Several viral repressors of the RIG-I/
MDA5 pathway have been described, but bacterial
repressors of RIG-I/MDA5 are not known. Thus, our study
provides novel insights into the molecular mechanisms by
which the immune system detects bacterial infection, and
conversely, by which bacteria suppress innate immune
responses.
Type I Interferon Response to L. pneumophila
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test this hypothesis, we determined whether macrophages deficient
in known cytosolic RNA and DNA sensing pathway components
can induce type I IFNs in response to L. pneumophila. Macrophages
were infected with L. pneumophila at a multiplicity of infection
(MOI) of 1 and induction of interferon beta (Ifnb) message was
analyzed by quantitative RT-PCR after 4 hours (Figure 1A–D). As
previously reported [29], Ips-12/2 macrophages showed a
significantly reduced induction of Ifnb in response to infection
with wild type L. pneumophila compared to Ips-1+/+ macrophages
(p,0.05; Figure 1A). Induction of Ifnb was not completely
eliminated in Ips-12/2 macrophages, however, as Irf32/2
macrophages exhibited an even lower induction of Ifnb compared
to Ips-12/2 (p,0.05; Figure 1A). Consistent with previous reports
[15], we found that the Dot/Icm type IV secretion system was
required to elicit the macrophage type I interferon response since
Ddot L. pneumophila did not induce a robust type I interferon
response (Figure 1A). These results suggest that L. pneumophila
induces type I IFN via a cytosolic RNA immunosurveillance
pathway that involves the adaptor Ips-1.
We hypothesized that a cytosolic RNA sensor that functions
upstream of Ips-1 could be involved in the type I interferon host
response to L. pneumophila. However, knockdown experiments in
A549 cells previously failed to reveal a role for the known sensors
(MDA5 and RIG-I) upstream of IPS-1 [14]. Therefore, we tested
Mda52/2 knockout macrophages (Figure 1B) and found reduced
induction of Ifnb message as compared to control Mda5+/+
macrophages. Importantly, however, Dot-dependent induction of
type I IFN was not completely abolished in Mda52/2 macro-
phages, implying that other redundant pathways are also involved.
Rig-i knockout mice die as embryos, so we were unable to obtain
Rig-i2/2 knockout macrophages. To circumvent this problem, we
stably transduced immortalized macrophages with a retrovirus
expressing an shRNA to knock down Rig-i expression. Quantita-
tive RT-PCR demonstrated that the knockdown was effective,
even in infected macrophages (Figure 1C), and that Rig-i
knockdown had a significant effect on the induction of type I
interferon by L. pneumophila (Figure 1D). In the experiments in
Figures 1C and 1D we used the DflaA strain of L. pneumophila, but
similar results were obtained with wildtype, and it was previously
shown that flagellin is not required for the IFN response to L.
pneumophila [14,16]. It is unusual, but not unprecedented, that a
pathogen would stimulate both the RIG-I and MDA5 RNA-
sensing pathways [47].
At present, only one candidate cytosolic DNA sensor involved in
the IFN response has been described [30,31]. To determine
whether this sensor, called Dai (or Zpb1), is involved in the type I
interferon response to L. pneumophila, we tested whether Zbp12/2
macrophages respond to L. pneumophila. We observed similar levels
of Ifnb induction in Zbp1+/+ and Zbp12/2 macrophages
(Figure 1E). Taken together, these results imply that the RNA
sensors Rig-i and Mda5, but not the DNA sensor Zbp1, are
involved in sensing L. pneumophila infection.
We tested whether loss of signaling through the RNA sensing
components Ips-1 or Mda5 could mimic the previously observed
permissiveness of Ifnar2/2 macrophages [16]. However, neither
Ips-12/2 nor Mda52/2 macrophages were permissive to L.
pneumophila, suggesting that the low levels of IFNb produced in
the absence of Ips-1 or Mda5 are sufficient to restrict L. pneumophila
growth (Figure S1).
The type IV secreted effector SdhA suppresses induction
of interferon by L. pneumophila
To identify bacterial components that modulate the type I
interferon response to L. pneumophila, we conducted a transposon
mutagenesis screen. The LP02 strain of L. pneumophila was
mutagenized with a mariner transposon as described previously
[12]. Individual transposon mutants were used to infectMyD882/2
Trif2/2 bone marrow-derived macrophages at an MOI of 1, and
after approximately 16 hours, supernatants were collected and
overlayed on type I IFN reporter cells [48]. Induction of type I IFN
was compared to wild type (LP02) and Ddot L. pneumophila controls.
We tested approximately 2000 independent mutants and isolated
eight mutants that were confirmed to be defective in induction of
type I IFN. All these mutants harbored insertions in genes required
for the function of the Dot/Icm apparatus (e.g., icmB, icmC, icmD,
icmX, icmJ), thereby validating the screen.
Interestingly, a single transposon mutant, 11C11, was found
that consistently hyperinduced the type I interferon response. The
transposon insertion mapped to the 39 end (nucleotide position
3421 of the open reading frame) of a gene, sdhA, that was
previously shown [4] to encode a type IV secreted effector protein
of 1429 amino acids (166kDa) (Figure 2A). SdhA has previously
been shown to be essential for bacterial replication in macrophages
[4], but a connection to type I IFNs was not previously noted.
To confirm that the hyperinduction of type I interferon was due
to mutation of sdhA, the 11C11 transposon mutant was compared
to an unmarked clean deletion of sdhA (Figure 2B). Both the 11C11
mutant and DsdhA L. pneumophila showed similar levels of
hyperinduction of type I interferon. The L. pneumophila genome
contains 2 paralogs of sdhA, called sidH and sdhB. A triple knockout
strain, DsdhADsdhBDsidH, was compared to single deletion of sdhA
to determine if either paralog regulated the induction of type I
IFNs. Similar levels of IFNb were induced DsdhADsdhBDsidH and
DsdhA (Figure 2B). Similar results were obtained when induction of
Ifnb was assessed by quantitative RT-PCR (Figure 2C). A role for
sdhA in regulating the interferon response was further confirmed
by complementing the DsdhA mutation with an sdhA expression
plasmid [4]. As expected, the complemented strain induced
significantly less type I IFN than the control DsdhA strain
harboring an empty plasmid (Figure 2D). These results indicate
that SdhA functions, directly or indirectly, to repress the induction
of type I IFN by L. pneumophila.
Hyperinduction of type I IFN by the sdhA mutant involves
the cytosolic RNA-sensing pathway
It was possible that DsdhA mutants hyperinduced type I IFN via
a pathway distinct from the normal cytosolic RNA-sensing
pathway that responds to wildtype L. pneumophila. Therefore, to
determine whether hyperinduction of type I interferon by DsdhA
occurs through the same pathway that responds to wild type L.
pneumophila, we infected Ips-12/2 and Mda52/2 macrophages with
DsdhA L. pneumophila. Induction of Ifnb message was determined by
quantitative RT-PCR. The hyperinduction of Ifnb seen in Ips-1+/+
macrophages was almost abolished in Ips-12/2 macrophages
(p,0.001; Figure 3A). As a control, induction of Ifnb by poly I:C, a
double-stranded synthetic RNA analog, was also Ips-1-dependent
as expected. Similarly, the hyperinduction of Ifnb was also reduced
in Mda52/2 macrophages (p,0.01; Figure 3B). However, the
Mda52/2 macrophages still induced significant amounts of Ifnb,
suggesting that the requirement for Mda5 is not complete. We also
tested the DsdhA mutant in Rig-i knockdown macrophages. Rig-i
knockdown appeared to be effective (Figure 3C) and specifically
diminished Ifnb expression (Figure 3D). Thus, the residual Ifnb
induction in Mda52/2 may be due to Rig-i, or to another
uncharacterized pathway. As a control, Theiler’s virus (TMEV)
induced Ifnb in a completely Mda5-dependent manner, as expected
(Figure 3B).
Type I Interferon Response to L. pneumophila
PLoS Pathogens | www.plospathogens.org 3 November 2009 | Volume 5 | Issue 11 | e1000665
Figure 1. The cytosolic RNA-sensing pathway is involved in the host type I interferon response to L. pneumophila. (A) Induction of
interferon beta (Ifnb) by L. pneumophila is largely dependent on Ips-1. Bone marrow derived Ips-1+/+, Ips-12/2, and Irf32/2 macrophages were infected
with wild type and Ddot L. pneumophila at a multiplicity of infection (MOI) of 1. Ifnb induction was analyzed by quantitative RT-PCR 4 hours post
infection. Ifnb message was normalized to ribosomal protein rps17 levels. Differences in Ifnb transcript induction were statistically significant in Ips-1+/+
versus Ips-12/2 macrophages (*, p,0.05) and Ips-12/2 versus Irf32/2 (*, p,0.05, Student’s t-test) when infected with wild type L. pneumophila. (B)
Induction of Ifnb by L. pneumophila is partially dependent on Mda5. Bone marrow derived Mda5+/+ and Mda52/2 macrophages were infected with
wild type and Ddot L. pneumophila at a multiplicity of infection (MOI) of 1. Ifnb induction was assessed by quantitative RT-PCR as in (A). Differences in
Ifnb induction were statistically significant (*, p,0.05, Student’s t-test) between Mda5+/+ and Mda52/2 infected with wild type L. pneumophila. (C)
Retroviral transduction of a Rig-i shRNA, but not the control shRNA, knocks down expression of Rig-i in MyD882/2Trif2/2 immortalized macrophages.
Stable transduction of MyD882/2Trif2/2 immortalized macrophages was performed with a retroviral vector containing a control and Rig-i shRNA.
Level of Rig-i knockdown was determined by quantitative RT-PCR under uninfected, infected, and poly I:C stimulation conditions. Differences in Rig-i
transcript levels were statistically significant (*, p,0.05, Students t-test) under resting, infected, and ligand-stimulated conditions. (D) Rig-i is involved
in the host type I interferon response to infection with L. pneumophila. Rig-i knockdown leads to reduced Ifnb expression in response to infection with
DflaA L. pneumophila, as well as stimulation with poly I:C. Quantitative RT-PCR was carried out 4 hours post infection. Control knockdown
macrophages induced a statistically significant (*, p,0.05) higher level of Ifnb transcript in response to DflaA L. pneumophila and poly I:C. No
significant difference was found in uninfected or Ddot L. pneumophila infected macrophages. (E) Induction of Ifnb by L. pneumophila is independent
of Zbp-1 (Dai). Bone marrow derived Zbp-1+/+ and Zbp-12/2macrophages were infected with L. pneumophila strains and analyzed for Ifnb induction as
in (A) and (B). Differences in Ifnb transcript levels between Zbp-1+/+ and Zbp-12/2 macrophages infected with L. pneumophila were not statistically
significant (ns, p.0.1, Student’s t-test).
doi:10.1371/journal.ppat.1000665.g001
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Figure 2. The type IV secreted effector SdhA suppresses induction of interferon by L. pneumophila. (A) The 11C11 mutant harbors a
transposon insertion in sdhA. The transposon insertion site is in the 39 end of the open reading frame of the sdhA locus at nucleotide position 3421. (B) A
clean deletion mutant of sdhA recapitulates the 11C11 transposon mutant and hyperinduces type I interferon. Bone marrow derived Myd882/2
Trif2/2 macrophages were infected with stationary phase L. pneumophila strains at a MOI of 1. Cell supernatants were harvested 8 hours post
infection and assayed for type I interferon induction by an L929-ISRE luciferase bioassay. Type I interferon levels were determined by generating a
standard curve with recombinant IFNb An unmarked clean deletion of sdhA was compared to wild type, Ddot, the transposon mutant 11C11, and a
triple deletion of sdhA and the two L. pneumophila paralogs, sidH and sdhB. Differences in IFNb induction were statistically significant between WT L.
pneumophila and the transposon mutant 11C11 (***, p,0.0005, Student’s t-test). Differences between 11C11, DsdhA and DsdhADsdhBDsidHwere not
statistically significant (ns, p.0.05, Student’s t-test). (C) A clean deletion mutant of sdhA recapitulates the 11C11 transposon mutant and
hyperinduces transcriptional activation of Ifnb. Bone marrow derived Myd882/2Trif2/2 macrophages were infected with wild type, Ddot, DsdhA,
11C11, DsdhADsdhBDsidH stationary phase L. pneumophila and transcriptional induction of Ifnb was analyzed by quantitative RT-PCR. (D)
Complementation of the sdhAmutant results in loss of the Ifnb hyperinduction phenotype.MyD882/2Trif2/2 BMDMwere infected at an MOI of 1 with
DflaA, Ddot, DflaADsdhA and DflaADsdhA L. pneumophila carrying vector or a plasmid expressing full length SdhA. Expression of Ifnb message was
assessed by quantitative RT-PCR 4 hours post infection.
doi:10.1371/journal.ppat.1000665.g002
Type I Interferon Response to L. pneumophila
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The effects of the DsdhA mutant are independent of
caspase-1 activation
It was previously shown that DsdhA mutants induce a rapid
death of infected macrophages that is dependent upon activation
of multiple cell death pathways [4]. Consequently, we hypothe-
sized that the hyperinduction of type I IFN by the DsdhA mutant
might be due to the release of molecules from dying cells, such as
DNA, that could induce Ifnb expression. To rule out this
explanation, we infected Casp12/2 macrophages, which are
resistant to cell death at the early timepoints examined (e.g., 4h
post infection), and asked whether type I interferon was still
hyperinduced in response to DsdhA L. pneumophila. In fact, we found
that Casp12/2macrophages infected with the DsdhA mutant
hyperinduced Ifnb to levels above that observed in B6 macro-
phages (Figure 4A). We suspect that the increased Ifnb induction
seen in Casp12/2 cells was an indirect consequence of the lower
levels of cell death in these cells, and was not due to a specific
suppression of type I interferon transcription by Casp1 activation.
In any case, our results indicated that the hyperinduction of type I
IFN by the DsdhA mutant was not due to increased cell death
induced by the mutant. As a control, we confirmed that Casp12/2
macrophages were resistant to cell death at the 4h timepoint tested
(Figure 4B).
SdhA acts independently of the type I IFN receptor
Induction of Ifnb is often regulated by a positive feedback loop in
which initial production of IFNb results in signaling through the type
I IFN receptor (Ifnar) and synergistically stimulates the production of
additional type I IFN. We therefore examined whether the
hyperinduction of Ifnb by the DsdhAmutant might be due to positive
Figure 3. Hyperinduction of type I IFN by sdhAmutants involves cytosolic RNA sensing pathway components Ips-1, Rig-i, and Mda5.
(A) Hyperinduction of Ifnb by DsdhA L. pneumophila is largely dependent on Ips-1. Bone marrow derived Ips-1+/+ and Ips-12/2 macrophages were
infected with wild type, Ddot, and DsdhA L. pneumophila at an MOI of 1. Ips-1+/+ and Ips-12/2macrophages were transfected with 1.0 mg/ml poly I:C. 4
hours post infection and stimulation, macrophages were harvested and assessed for Ifnb induction as in Figure 1. Ips-1+/+ infected with WT L.
pneumophila induced statistically significant higher levels of Ifnb transcript than Ips-12/2 (**, p,0.005, Student’s t-test). The same phenotype was
seen in Ips-1+/+ infected with DsdhA L. pneumophila (**, p,0.005) and transfected with poly I:C (*, p,0.05) when compared to Ips-12/2. (B)
Hyperinduction of Ifnb by DsdhA L. pneumophila is partially dependent on Mda5. Bone marrow derived Mda5+/+ and Mda52/2 macrophages were
infected with DflaA, Ddot, and DflaADsdhA L. pneumophila at an MOI of 1. Theiler’s virus (TMEV) was overlaid onto Mda5+/+ and Mda52/2
macrophages. 4 hours post bacterial and viral infection, macrophages were harvested and assessed for Ifnb induction by qRT-PCR as in Figure 1. Ifnb
message was induced statistically significantly in Mda5+/+ macrophages infected with DflaA L. pneumophila versus Mda52/2 (*, p,0.05, Student’s t-
test). Mda5+/+ also responded statistically significantly to DflaADsdhA L. pneumophila over Mda52/2 (*, p,0.05, Student’s t-test), while Theiler’s virus
elicited a robust Ifnb response from Mda5+/+ not seen in Mda52/2 (***, p,0.005, Student’s t-test). (C) Retroviral transduction of a Rig-i shRNA, but not
the control shRNA, knocks down expression of Rig-i. MyD882/2Trif2/2 immortalized macrophages were stably transduced with retroviral vector
containing a control and Rig-i shRNA. Level of Rig-i knockdown was determined by quantitative RT-PCR under uninfected and infected conditions.
Differences in Rig-i transcript levels were statistically significant (*, p,0.05, Students t-test) under resting and infected conditions. (D) Rig-i is involved
in the hyperinduction of type I interferon by DsdhA L. pneumophila. Rig-i knockdown leads to reduced Ifnb expression in response to infection with
WT and DsdhA L. pneumophila, as well as Sendai virus. Quantitative RT-PCR was carried out 4 hours post infection. Control knockdown macrophages
induced a statistically significant (*, p,0.05) higher level of Ifnb transcript in response to WT and DsdhA L. pneumophila and Sendai virus. No
significant difference was found in uninfected or Ddot L. pneumophila infected macrophages.
doi:10.1371/journal.ppat.1000665.g003
Type I Interferon Response to L. pneumophila
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feedback through the type I IFN receptor. To test this possibility we
examined induction of Ifnb by the DsdhA mutant in Ifnar2/2
macrophages. We found that hyperinduction of Ifnb by DsdhA L.
pneumophila occurs even in the absence of signaling from the type I
interferon receptor, since Ifnar2/2 macrophages hyperinduce Ifnb in
response to infection with DsdhA L. pneumophila (Figure 4A).
The mechanism by which the DsdhA mutant induces cell death
remains unclear [4]. Studies with the intracellular bacterial
pathogen Francisella tularensis have demonstrated the existence of
a type I IFN-inducible caspase-1-dependent cell death pathway
[43]. Therefore, we sought to establish if caspase-1-dependent cell
death occurred in the absence of Ifnar signaling in response to wild
type and DsdhA L. pneumophila. Ifnar2/2 macrophages were infected
at an MOI of 1 and assayed for release of the intracellular enzyme
lactate dehydrogenase (LDH) 4 hours post infection. Ifnar2/2
macrophages exhibited similar LDH release as B6 macrophages,
whether infected with WT or DsdhA L. pneumophila, and this LDH
release was dependent upon caspase-1 activation (Figure 4B).
These data demonstrate that caspase1-dependent pyroptotic death
occurs independently of the type I interferon receptor during
infection with wild type and DsdhA L. pneumophila.
Since growth of the DsdhA mutant is severely attenuated in
macrophages [4], we hypothesized that hyperinduction of type I
interferon might contribute to the restriction of replication of the
DsdhA mutant. To test this hypothesis, we infected lfnar2/2
macrophages with luminescent strains of L. pneumophila at an MOI
of 0.01 and monitored bacterial replication over a 72 hour time
period. As previously reported [16], lfnar2/2 macrophages were
more permissive to WT and DflaA L. pneumophila as compared to
C57BL/6 macrophages (Figure S2A, C). However, the DsdhA or
DflaADsdhA L. pneumophila strains were still significantly restricted in
Ifnar2/2 macrophages (Figure S2B, D). Thus, SdhA is required for
bacterial replication in macrophages primarily via a mechanism
independent of its role in suppressing type I IFN. As expected, Ddot
L. pneumophila did not replicate in WT or Ifnar2/2 macrophages
(Figure S2E).
Since SdhA is a secreted effector, we hypothesized that SdhA
may act in the host cell cytosol, rather than in the bacterium, to
repress Ifnb induction. To test this hypothesis, we co-expressed
SdhA with MDA5 or RIG-I, by transient transfection of
HEK293T cells, and assessed interferon expression with an
IFNb-luciferase reporter. Expression of either MDA5 or RIG-I
robustly induced the IFNb-luc reporter upon stimulation with poly
I:C (Figure S3). When SdhA was co-expressed with MDA5, a
dose-dependent repression of the IFNb-luc reporter was observed
(Figure S3A). Co-expression of SdhA also resulted in a dose-
dependent repression of RIG-I-dependent induction of the IFNb-
luc reporter (Figure S3B). However, SdhA co-expression did not
affect TRIF-dependent induction of the IFNb-luc reporter (Figure
S3C), arguing against the possibility that SdhA expression has
non-specific effects on IFNb-luc induction. These results must be
interpreted with caution since the 293T IFNb-luc reporter system
is highly artificial; moreover, we have not demonstrated a direct
interaction of SdhA with signaling components in the RNA-
sensing pathway. In fact, the reported effects of SdhA on
mitochondria [4] suggest the effect may be somewhat indirect
(see Discussion). Nevertheless, the 293T transfection results suggest
that SdhA can act in the host cytosol to specifically repress
induction of the RIG-I/MDA5 pathway.
L. pneumophila genomic DNA does not appear to
stimulate an Ips-1-dependent IFN response
Based on our observation that the host type I IFN response
requires the L. pneumophila Dot/Icm type IV secretion system and
was at least partly Ips-1, Rig-i, and Mda5-dependent, we
hypothesized that L. pneumophila nucleic acids (RNA, DNA or
both) might gain access to the macrophage cytosol via the type IV
secretion system and induce a host type I interferon response. To
test if L. pneumophila nucleic acids are sufficient to induce type I
interferon, we transfected MyD882/2Trif2/2 macrophages with
purified L. pneumophila genomic DNA or total RNA and
determined the induction of type I interferons by bioassay.
Figure 4. The effects of the sdhA mutation on type I interferon induction are independent of caspase-1 activation and the type I
interferon receptor. (A) Type I interferon receptor signaling and caspase1-dependent pyroptotic cell death are not required for superinduction of
Ifnb by the sdhA mutant. Bone marrow derived C57BL/6, Ifnar2/2 and Casp12/2 macrophages were infected with wild type, Ddot, and DsdhA L.
pneumophila at an MOI of 1. Ifnb message was analyzed by qPCR from macrophage RNA harvested 4 hours post infection. (B) Caspase1-dependent
pyroptotic cell death occurs independently of the type I interferon receptor. Bone marrow derived C57BL/6, Ifnar2/2 and Casp12/2 macrophages
were infected with wild type, Ddot, and DsdhA L. pneumophila at an MOI of 1 and release of lactate dehydrogenase (LDH) in cell supernatants was
measured 4 hours post infection. Specific cell lysis was calculated as a percentage of detergent lysed cells with spontaneous LDH release subtracted.
No statistically significant difference was found between B6 and Ifnar2/2 macrophages infected with DsdhA L. pneumophila (p.0.1, Student’s t-test).
ND, not detected.
doi:10.1371/journal.ppat.1000665.g004
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Poly(dA-dT):poly(dA-dT) (abbreviated as pA:T) was used as a non-
CpG containing DNA control and poly I:C was used as an RNA
control. Nucleic acid preparations were treated with DNase and/
or RNase to eliminate contaminating nucleic acids. Both purified
L. pneumophila DNA and the crude RNA preparation induced
IFNb (Figure 5A). L. pneumophila RNA treated with RNase also
induced IFNb, presumably due to (contaminating) DNA in the
preparation (Figure 5A). However, L. pneumophila RNA treated
with DNase induced type I interferon to a level above that induced
by L. pneumophila RNA treated with both RNase and DNase,
suggesting that L. pneumophila RNA alone can induce type I
interferon production (Figure 5A). The induction of type I IFN by
L. pneumophila RNA was modest, possibly because bacterial RNA is
less stable than DNA. Nevertheless, these results suggest that both
L. pneumophila RNA and DNA can induce a type I interferon host
response.
Next, we determined if L. pneumophila nucleic acids could induce
type I interferon in an Ips-1-dependent manner in macrophages.
In certain cell types, though not mouse macrophages [34], AT-
rich DNA has been shown to induce type I IFN via IPS-1
[26,27,28,29]. It was important to assess whether L. pneumophila
DNA, in particular, might signal in an Ips-1-dependent manner
since the L. pneumophila type IV secretion system has previously
been shown to translocate DNA [46]. Ips-1+/2 and Ips-12/2
macrophages were transfected with pA:T and L. pneumophila DNA,
as well as infected with Sendai virus, a virus previously determined
to induce an Ips-1-dependent IFN response. Stimulation with
pA:T or L. pneumophila DNA failed to induce Ifnb in an Ips-1-
dependent manner, whereas Sendai virus induced significantly
more Ifnb in Ips-1+/2 versus Ips-12/2 macrophages (Figure 5B).
Similar results were obtained in Mda52/2 macrophages: induction
of type I IFN with pA:T or L. pneumophila genomic DNA showed
no requirement for Mda5, whereas a control simulation, Theiler’s
Virus, showed Mda5-dependent induction of IFNb, as expected
(Figure 5C). It was possible that at high concentrations of DNA, an
Ips-1-independent DNA-sensing pathway overwhelmed any puta-
tive Ips-1-dependent recognition of DNA. However, induction of
Ifnb was independent of Ips-1 even when titrated amounts of pA:T
or L. pneumophila genomic DNA were transfected into macrophages
(Figure 5D, 5E). Thus, these results suggest that while transfected
L. pneumophila DNA robustly induces type I interferon, L.
pneumophila genomic DNA does not appear to induce the Ips-1-
dependent IFN response that is characteristic of L. pneumophila
infection.
L. pneumophila RNA stimulates type I interferon via Rig-i
To determine whether L. pneumophila RNA could be recognized
by Rig-i, we transfected L. pneumophila RNA into macrophages in
which Rig-i expression had been stably knocked down. Impor-
tantly, the Rig-i knockdown was performed in immortalized bone-
marrow-derived macrophages that lack MyD88 and Trif, in order
to avoid potential activation of known RNA-sensing TLRs.
Knockdown of Rig-i was effective under our transfection
conditions, as Rig-i message was significantly lower in macrophag-
es transduced with a Rig-i shRNA compared to a control shRNA
(p,0.05; Figure 6A). Crude L. pneumophila RNA (which also
contains genomic DNA contaminants) induced Ifnb robustly in
both control shRNA and Rig-i shRNA macrophages, even upon
treatment with RNase A (Figure 6B). However, transfection of
DNase-treated L. pneumophila nucleic acids induced significantly
less Ifnb in Rig-i knockdown macrophages as compared to control
knockdown macrophages (p,0.05; Figure 6B.) This result suggests
that L. pneumophila RNA can induce Rig-i-dependent type I
interferon. It was not possible to perform a similar experiment in
the Ips-12/2 macrophages because these macrophages were
MyD88/Trif+ and exhibited background interferon, presumably
due to TLR3 signaling.
RNA polymerase III does not appear to be required for
the IFN response to L. pneumophila
A recent report found that an inhibitor of RNA polymerase III,
ML-60218 [49], blocked the type I IFN response to L. pneumophila
[29]. It was proposed that L. pneumophila DNA is translocated into
macrophages and transcribed by Pol III into a ligand that could be
recognized by RIG-I [29]. In contrast, we did not see an effect of
ML-60218 on induction of type I IFN by L. pneumophila in bone
marrow-derived macrophages (Figure 7A). The lack of an effect
does not appear to be due to redundant recognition by another
DNA sensor in macrophages because the interferon induction was
still largely Ips-1-dependent (Figure 7A). Because our results with
the Pol III inhibitor were negative, we cannot rule out the
possibility that the Pol III inhibitor fails to function in
macrophages. However, we also tested 293T cells, which express
only the Pol III pathway for cytosolic recognition of DNA [28,29].
As expected, 293T cells responded to pA:T in an ML-60218-
inhibitable manner, but did not respond well to L. pneumophila
genomic DNA (Figure 7B), again suggesting that L. pneumophila
genomic DNA is not an efficient substrate for the Pol III pathway.
The Pol III inhibitor also appeared to have little effect on L.
pneumophila replication in bone-marrow macrophages (Figure 7C–
E). This latter result was expected, since we found that even Ips-
12/2 macrophages exhibit normal restriction of L. pneumophila
replication (Figure S1), despite significantly reduced IFN
induction.
In vivo role of Ips-1 in the host type I interferon response
to L. pneumophila
In order to validate our findings in vivo, we infected Ips-12/2
and littermate Ips-1+/2 mice with L. pneumophila (2.56106 LP01
DflaA per mouse, infected intranasally) and assayed type I
interferon production in bronchoalveolar lavage fluid 20 hours
post infection by bioassay. Ips-1+/2 mice induced an IFN response
that was statistically significantly greater than the response of Ips-
12/2 mice (Student’s t-test, p = 0.01; Figure 8A). The difference in
IFN production was not explained by a difference in bacterial
burden in the Ips-1+/2 and Ips-12/2 mice, since both genotypes
exhibited similar levels of bacterial colonization (p= 0.76,
Student’s t-test; Figure 8B). The lack of an effect of Ips-1-
deficiency on bacterial replication in vivo was not surprising given
that we also failed to observe an effect of Ifnar-deficiency on
bacterial replication in vivo (data not shown). We suspect that type
II IFN (IFNl), which is not made by macrophages in vitro, or
another in vivo pathway, may compensate for loss of type I IFN in
vivo. Nevertheless, our results provided an important validation of
our in vitro studies and affirm a role for Ips-1 in the in vivo type I
interferon response to L. pneumophila. Since Ips-1-deficient mice still
mounted a measurable IFN response in vivo, it appears that
additional Ips-1-independent pathways (e.g., TLR-dependent
pathways, possibly involving other cell types [50]) also play a role
in vivo.
Discussion
Type I interferons (IFNs) have long been appreciated as critical
players in antiviral immune defense, and recent work has
identified several molecular immunosurveillance pathways that
induce type I IFN expression in response to viruses [18,19]. In
contrast, the roles of type I IFNs in response to bacteria, and the
Type I Interferon Response to L. pneumophila
PLoS Pathogens | www.plospathogens.org 8 November 2009 | Volume 5 | Issue 11 | e1000665
Figure 5. L. pneumophila DNA and RNA stimulate type I IFN production in macrophages. (A) Purified genomic DNA and RNA from L.
pneumophila induces type I interferon independently of MyD88 and Trif. Bone marrow derived Myd882/2Trif2/2 macrophages were stimulated by
transfection of 3.3 mg/ml purified L. pneumophila DNA, L. pneumophila RNA, pA:T (DNA), and pI:C (RNA). Nucleic acids were treated with DNase and/or
RNase A before transfection. Macrophage supernatants were harvested 8 hours post stimulation and analyzed for IFNb levels by L929-ISRE luciferase
bioassay. IFNb production by DNase-treated L. pneumophila RNA was statistically significantly higher compared to DNase-treated L. pneumophila DNA
(**, p,0.005). In addition, RNase A-treated L. pneumophila RNA produced statistically significant lower levels of IFNb (***, p,0.0001, Student’s t-test)
than L. pneumophila RNA and RNase-treated L. pneumophila DNA. (B) Genomic L. pneumophila DNA does not induce type I interferon in a Ips-1-
dependent manner. Ips-12/2 and heterozygous littermate bone marrow derived macrophages were stimulated by transfection of 1.0 mg/ml pA:T and
purified genomic L. pneumophila DNA. Macrophages were infected with DflaA L. pneumophila at an MOI of 1. Sendai virus (SeV) was overlaid onto Ips-
12/2 and heterozygous littermate macrophages. Transcriptional activation of Ifnb was determined by quantitative RT-PCR as described in Figure 1. (C)
The viral RNA sensor Mda5 is not required for induction of type I interferon by L. pneumophila DNA. WT (C57BL/6) and Mda52/2 bone marrow derived
macrophages were stimulated by transfection of 1.0 mg/ml pA:T and purified genomic L. pneumophila DNA. Sendai virus (SeV) and Theiler’s virus
(TMEV) were overlaid onto WT and Mda52/2macrophages. Quantitative RT-PCR was used to determine Ifnb gene expression. (D) Non-CpG containing
DNA (pA:T) does not induce Ips-1-dependent Ifnb at all concentrations tested. Ips-12/2 and heterozygous littermate bone marrow derived
macrophages were stimulated with a titration of pA:T by transfection of 10, 1.0, 0.1, 0.01 mg/ml pA:T. The difference between Ips-1+/2 and Ips-12/2
macrophages transfected with pA:T was not statistically significant (ns, p.0.1, Student’s t-test). Sendai virus (SeV) was overlaid onto Ips-12/2 and
heterozygous littermate macrophages (**, p,0.005). Cell supernatants were collected 8 hours post stimulation/infection. Induction of type I
interferon was determined by L929-ISRE luc bioassay. Units are relative light units (RLU). (E) Genomic L. pneumophila DNA induces type I interferon
independently of Ips-1 at all concentrations tested. Ips-12/2 and heterozygous littermate bone marrow derived macrophages were stimulated with a
titration of purified genomic L. pneumophila DNA by transfection of 10, 1.0, 0.1, 0.01 mg/ml L. pneumophila DNA. No statistically significant difference
was found between Ips-1+/2 and Ips-12/2macrophages transfected with genomic L. pneumophila DNA (ns, p.0.1, Student’s t-test). Sendai virus (SeV)
was overlaid onto Ips-12/2 and heterozygous littermate controls (**, p,0.005). Macrophage supernatants were collected 8 hours post stimulation/
infection. Type I interferon levels were determined by L929-ISRE luc bioassay, units are relative light units (RLU).
doi:10.1371/journal.ppat.1000665.g005
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pathways by which bacteria induce type I IFNs, are considerably
less well understood. In this study, we sought to characterize the
type I IFN response to the gram-negative bacterial pathogen
Legionella pneumophila. Our study focused on the type I IFN response
mounted by macrophages, since this is the cell type that is believed
to be the primary replicative niche in the pathogenesis of
Legionnaires’ Disease.
In agreement with previous work [15], we found that L.
pneumophila induces type I IFNs in macrophages via a TLR-
independent pathway that requires expression of the bacterial type
IV secretion system. These results suggested that a cytosolic
immunosurveillance pathway controls the IFN response in
macrophages. In this report we identify the cytosolic RNA-sensing
pathway as a key responder to L. pneumophila infection (Figure 1)
and, in agreement with previous results using human A549 cells
[51], we did not observe a role for Dai (Zbp1), a gene implicated in
the response to cytosolic DNA [30,31]. A previous study using
RNA interference in the human A549 epithelial-like cell line also
found a role for IPS-1 in the type I IFN response to L. pneumophila
[14]. However, knockdown of RIG-I or MDA5 did not appear to
affect the IFN response [14], so the role of the IPS-1 pathway was
unclear. In our study, we used mice harboring targeted gene
deletions to establish a role for Mda5 and Ips-1 in the type I IFN
response to L. pneumophila in macrophages, and uncovered a role
for Rig-i using an shRNA knockdown strategy. We also found that
the cytosolic RNA-surveillance pathway regulated the IFN
response in vivo in a mouse model of Legionnaires’ Disease.
After our manuscript was submitted, a report published by Chiu
and colleagues also concluded that Ips-1 is required for the
macrophage type I IFN response to L. pneumophila [29]. However,
the report of Chiu et al differs considerably from our current work
by proposing that the type I IFN response to L. pneumophila occurs
via a novel and unexpected pathway in which L. pneumophila DNA
reaches the host cytosol and is transcribed by RNA polymerase III
to generate an RNA intermediate that is sensed by RIG-I. Others
have found that the Pol III pathway can be activated by viral and
AT-rich DNA in certain cell types [28]. Our data, however, are
not easily reconciled with a role for the Pol III pathway in
recognition of L. pneumophila. First, and perhaps most important, is
the observation that the response to DNA (in contrast to the
response to L. pneumophila infection) has never been seen to be Ips-
1-dependent in macrophages ([34]; Figure 5). This suggests that
the response to L. pneumophila is not simply a response to DNA,
regardless of the mechanisms by which potentially translocated
DNA might be recognized.
We considered the possibility that L. pneumophila DNA exhibits
unique properties that cause it to be a particularly efficient
substrate for the Pol III pathway. Indeed, the L. pneumophila
genome does contain stretches of highly AT-rich DNA, and it has
been reported that only highly AT-rich DNA is an efficient
substrate for the Pol III pathway [28,29]. Therefore we tested
whether L. pneumophila genomic DNA, unlike other DNA, could
induce an Ips-1-dependent response in macrophages. Although L.
pneumophila DNA induced a robust IFN response, the response was
not Ips-1-dependent (Figure 5B, E). Indeed, even the optimal Pol
III substrate poly(dA–dT):poly(dA–dT) (abbreviated as pA:T) does
not appear to induce an Ips-1-dependent IFN response in
macrophages (Figure 5B, D and [34]). The lack of Ips-1-
dependence in the response to pA:T appears to be due to an
unidentified Ips-1-independent DNA-sensing pathway that recog-
nizes pA:T and dominates over the Pol III pathway in bone
marrow macrophages [28]. Thus, if translocated DNA is the
relevant bacterial ligand that stimulates the Ips-1-dependent host
type I IFN response, an explanation is required for how the
dominant and unidentified DNA-sensing pathway is not activated.
While L. pneumophila could selectively inhibit or evade the
dominant DNA-sensing pathway, there is at present no evidence
to support this mechanism. Moreover, in our hands, the Pol III
inhibitor used by Chiu et al (ML-60218) failed to affect IFN
induction or bacterial replication in macrophages (Figure 7), in
contrast to what would be predicted if the Pol III pathway was
selectively activated in response to L. pneumophila infection.
Therefore, our data lead us to consider alternative models.
Although Chiu et al primarily used the RAW macrophage-like
cell line in their experiments with L. pneumophila, we do not believe
that cell-type-specific effects can account for the discrepancy in
Figure 6. L. pneumophila RNA induces type I interferon via Rig-i.
(A) The efficiency of Rig-i knockdown was determined by quantitative
RT-PCR under uninfected, viral and bacterial infected, and transfected
conditions. Differences in Rig-i transcript levels were statistically
significant (*, p,0.05, Students t-test) under resting, infected, and
transfected conditions. (B) Rig-i is involved in the host type I interferon
response to L. pneumophila RNA. Rig-i knockdown leads to reduced Ifnb
expression upon transfection with DNase-treated L. pneumophila RNA.
Quantitative RT-PCR was carried out 4 hours post stimulation. Control
knockdown macrophages induced a statistically significant (*, p,0.05)
higher level of Ifnb transcript in DflaA L. pneumophila and Sendai virus
infected macrophages. No significant difference was found in response
to untreated and RNase-treated L. pneumophila nucleic acids.
doi:10.1371/journal.ppat.1000665.g006
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results. Although it is possible that RAW cells express only the Pol
III pathway, this would not change the fact that the proposed
model of Chiu et al invokes DNA as the primary IFN-inducing
ligand produced by L. pneumophila. The simplest prediction of such
a model would be that the response of bone marrow macrophages
to L. pneumophila would be Ips-1-independent, as is the response of
macrophages to all forms of DNA that have been tested. In
contrast, as documented here (Figure 1) and by Chiu et al [29], the
response to L. pneumophila is Ips-1-dependent. Moreover, 293T cells,
which express only the Pol III DNA-sensing pathway [28,29],
failed to respond significantly to L. pneumophila genomic DNA,
despite a robust response to pA:T (Figure 7B). Therefore, our data
suggest that recognition of L. pneumophila genomic DNA by Pol III
is not responsible for the Ips-1-dependent IFN response to L.
pneumophila.
We considered two other models to explain how L. pneumophila
induces a type I interferon response. The first is that L. pneumophila
translocates RNA into host cells. In support of this model, we
demonstrate that L. pneumophila RNA, unlike any form of DNA
tested, induced a Rig-i-dependent type I IFN response in
macrophages (Figures 5A, 6). However, we did not demonstrate
that L. pneumophila RNA species are translocated into host cells,
and this will be important to examine in future studies.
Interestingly, it was recently reported that purified Helicobacter
pylori RNA stimulates RIG-I in transfected 293T cells [52]. A
second model to explain type I IFN induction by L. pneumophila is
that infection induces a host response that indirectly results in
signaling via the MDA5/RIG-I/IPS-1 pathways. L. pneumophila
secretes a large number of effectors into the host cytosol and these
effectors disrupt or alter a large number of host cell processes [53].
Such disruption may either lead to the generation of host-derived
RNA ligands for the RIG-I and MDA5 sensors, or may result in
signaling through these sensors in the absence of specific ligands. It
was previously proposed that a host nuclease, RNaseL, can
generate self-RNA ligands for the RIG-I and MDA5 pathways in
response to viral infection [54]. Although we could not observe a
Figure 7. The Pol III pathway does not appear to recognize L. pneumophila DNA or affect L. pneumophila replication. (A) Inhibition of
Pol III had no effect on Ips-1-dependent Ifnb induction by L. pneumophila. Ips-1+/2 and Ips-12/2 macrophages were pretreated (controls were
untreated) with 20 mM ML-60218 10 hours before infection with DflaA and DflaADsdhA L. pneumophila at an MOI of 1. Ifnb induction was analyzed by
quantitative RT-PCR 4 hours post infection. Ifnbmessage was normalized to ribosomal protein rps17 levels. (B) L. pneumophila genomic DNA does not
induce IFNB in HEK293T cells. HEK293T cells were pretreated, or left untreated, with 20 mM ML-60218 10 hours before transfection with 1.0 mg/ml
pA:T, L. pneumophila genomic DNA, or salmon sperm DNA. Ifnb induction was analyzed by quantitative RT-PCR 4 hours post infection. Ifnb message
was normalized to S9 levels. (C) WT (C57BL/6) macrophages were infected at an MOI of 0.01 in the presence or absence of 20 mM ML-60218 and
growth of luminescent L. pneumophila strains was determined by RLU at 0, 24, 48, and 72 hours post infection. For inhibitor conditions, macrophages
were pretreated with 20 mM ML-60218 10 hours before infection. Macrophages were infected with WT (LP02) L. pneumophila or with isogenic Ddot L.
pneumophila (D) DflaA L. pneumophila (E).
doi:10.1371/journal.ppat.1000665.g007
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role for RNaseL in the response to L. pneumophila (K.M. Monroe,
unpublished data), it is conceivable that a different host enzyme
can fulfill a similar function.
Our finding that a secreted bacterial effector, SdhA, previously
shown to suppress host cell death, also suppresses the IFN response
to L. pneumophila, is consistent with a model in which a host cell stress
response leads to direct or indirect activation of the cytosolic RNA-
sensing pathway. However, the mechanism by which SdhA acts on
host cells remains mysterious. Laguna and colleagues provided
evidence that SdhA is critical for prevention of mitochondrial
disruption that occurs when host cells are infected with the DsdhA
mutant [4]. Given that Ips-1 localizes to mitochondria and requires
mitochondrial localization for its function [21], it is tempting to
speculate that SdhA acts on mitochondria in a way that both
prevents their disruption and interferes with the function of Ips-1.
To provide evidence that SdhA acts specifically on the RIG-I/
MDA5 pathway, we used transient transfections of 293T cells.
SdhA repressed induction of Ifnb when co-expressed with Mda5 or
Rig-I but not Trif (Figure S3). Given these results and the evidence
that SdhA is translocated into host cells [4], we favor the idea that
SdhA acts within host cells. Mutation of sdhA was reported not to
affect translocation of other effectors into host cells [4]; thus, we tend
not to support the alternative possibility that SdhA blocks
translocation of the putative IFN-stimulatory ligand through the
type IV secretion system. SdhA is a large protein of 1429 amino
acids, but does not contain domains of known function, except for a
putative coiled coil (a.a. 1037–1068). In future studies it will be
important to address whether subdomains of SdhA can be identified
that are required for suppression of the IFN response. It will also be
important to determine whether these subdomains are distinguish-
able from any putative subdomains required for suppression of host
cell death. In fact, our data have suggested that suppression of cell
death and the IFN response may be separable functions of SdhA.
We found that cell death was not required for hyperinduction of
IFN by the DsdhA mutant, and conversely, we also found that
hyperinduction of type I IFN does not lead to increased cell death
(Figure 4).
Our studies demonstrate a partial role for both Mda5 and Rig-i
RNA sensors in response to L. pneumophila. Although these sensors
are typically thought to respond to distinct classes of viruses, there
are indications that they can also function cooperatively in
response to certain stimuli, e.g., West Nile Virus [47]. Our results
suggest that L. pneumophila produces ligands that can stimulate both
Mda5 and Rig-i and that these two sensors cooperatively signal via
Ips-1. Fitting with this model, we found that Ips-1-deficiency
generally had a more severe impact on type I IFN induction than
did Mda5 or Rig-i deficiency.
Cytosolic RNA-sensing pathways are believed to respond
exclusively to viral infection, and it is therefore surprising that L.
pneumophila appears to trigger these pathways. Other bacterial
species, such as Listeria monocytogenes and Francisella tularensis, have
been shown to induce an Ips-1-independent cytosolic pathway
leading to type I IFN induction [25,43,55]. The sensor(s) required
for the IFN response to Listeria or Francisella have not yet been
identified, but are widely assumed to be identical to the (also
unknown) sensor(s) that respond to cytosolic DNA [15,26].
Ips-1 or Mda5-deficiency, as well as Rig-i knockdown, did not
result in a complete elimination of the type I IFN response (Figure 1,
Figure 3). Thus, a cytosolic DNA-sensing pathway may also be
stimulated in response to L. pneumophila infection. A minor role for a
cytosolic DNA-sensing pathway would be consistent with the
observation that the L. pneumophila Dot/Icm type IV secretion
system can translocate DNA into recipient cells [46]. However, as
discussed above, our results with purified L. pneumophila DNA
suggest that cytosolic sensing of L. pneumophila DNA does not
account for the Ips-1-dependent induction of IFN that we observe
(Figure 5). One last possibility that we cannot eliminate is that a non-
DNA, non-RNA ligand is translocated into host cells and stimulates
the Ips-1 pathway. In fact, in separate work, we have found that a
small bacterial cyclic dinucleotide, c-di-GMP, can trigger a type I
IFN response in macrophages, but importantly, this response is
entirely independent of the Ips-1 pathway [34]. Nevertheless, there
may be other small molecules that can be translocated by the Dot/
Icm secretion system and signal in host cells via Ips-1.
Figure 8. Role of Ips-1 in the in vivo response to L. pneumophila. (A) The type I interferon response to L. pneumophila involves Ips-1 in vivo. Ips-
12/2 and heterozygous littermate mice were infected intranasally with 2.56106 LP01DflaA. Bronchoalveolar lavage with PBS was performed 20 hours
post infection. Type I interferon levels in the bronchoalveolar lavage fluid (BALF) were analyzed by bioassay and recombinant IFNb was used to
determine a standard curve. A two-tailed t-test determined the differences in IFNb levels were statistically significant (*, p,0.01, Student’s t-test)
upon comparison of Ips-1+/2 and Ips-12/2 mice. (B) L. pneumophila colony forming units are not significantly different in Ips-1+/2 and Ips-12/2.
Bronchoalveolar lavage fluid from infected Ips-1+/2 and Ips-12/2mice was centrifuged to isolate cells. Hypotonic lysis of cells was performed and CFU
were plated on buffered yeast extract charcoal plates with antibiotic selection for L. pneumophila. A two-tailed t-test determined that CFU in Ips-1+/2
and Ips-12/2 mice 20 hours post infection were not statistically significantly different (ns, p.0.5, Student’s t-test).
doi:10.1371/journal.ppat.1000665.g008
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Taken together, our results lead to new insights into the host
immunosurveillance pathways that provide innate defense against
bacterial pathogens. We demonstrate an unexpected role for a
viral RNA-sensing pathway in the response to L. pneumophila, and
identify a secreted bacterial effector, SdhA, that can suppress this
response. Our results therefore open new possibilities for
immunosurveillance of bacterial pathogens.
Materials and Methods
Ethics statement
Animal experiments were approved by the University of
California, Berkeley, Institutional Animal Care and Use Committee.
Mice, cell lines and plasmids
Bone marrow derived macrophages were derived from the
following mouse strains: C57BL/6J (B6), Ips-12/2 [25], Mda52/2
[56], Ifnar2/2 [57], Zbp12/2 [32], MyD88/Trif2/2, and Casp12/2
[58]. C57BL/6J mice were purchased from the Jackson Laboratory.
Ips-12/2 mice were from Z. Chen (University of Texas Southwest-
ern Medical Center). Ips-12/2 were obtained on a mixed B6/129
background and Ips-12/2 and Ips-1+/2 littermate controls were
generated by breeding (Ips-12/2 x B6) F1 mice to Ips-12/2.
Mda52/2 mice were fromM. Colonna and S. Gilfillan (Washington
University). L929-ISRE IFN reporter cells were from B. Beutler
(The Scripps Research Institute). Viruses to immortalizeMyD882/2
Trif2/2 immortalized bone marrow derived macrophages were the
generous gift of K. Fitzgerald, D. Golenbock (U. Mass, Worcester)
and D. Kalvakolanu (U. Maryland). The complementation plasmid
(pJB908-SdhA) was generously provided by R. Isberg (Tufts).
Expression constructs pEF-BOS-RIG-I and pEF-BOS-MDA5 were
generously provided by J. Jung (Harvard Medical School).
Bacterial strains
LP02 is a streptomycin-resistant thymidine auxotroph derivative
of Legionella pneumophila strain LP01. LP02DsdhA and
LP02DsdhADsdhBDsidH were a generous gift from R. Isberg (Tufts
University). The DflaADsdhA strain was generated by introducing
an unmarked deletion of flaA in LP02DsdhA using the allelic
exchange vector pSR47S-DflaA [12].
Cell culture
L929-ISRE and HEK293T cells were cultured in DMEM
supplemented with 10% FBS, 2 mM L-glutamine, 100 mM
streptomycin, and 100 U/mL penicillin. Macrophages were
derived from bone marrow cells cultured for eight days in RPMI
supplemented with 10% FBS, 2 mM L-glutamine, 100 mM
streptomycin, 100 U/mL penicillin, and 10% supernatant from
3T3-CSF cells, with feeding on the fifth day of growth. MyD882/2
Trif2/2 immortalized macrophages were cultured in RPMI
supplemented with 10% FBS, 2 mM L-glutamine, 100 mM
streptomycin, and 100 U/mL penicillin.
Reagents
Poly I:C was from GE Biosciences, pA:T (poly(dA-dT):poly(dA-
dT)) was from Sigma, and Sendai Virus was from Charles River
Laboratories. Wildtype Theiler’s Virus GDVII was from M.
Brahic and E. Freundt (Stanford University). Pol III inhibitor
(ML-60218) was from Calbiochem.
Isolation of nucleic acids from L. pneumophila
Total bacterial RNA was isolated using RNAprotect Bacterial
Reagent (Qiagen) and RNeasy kit (Qiagen). Genomic DNA was
isolated by guanidinium thiocyanate followed by phenol:chloro-
form extraction. Nucleic acids were treated with RQ1 RNase-Free
DNase (Promega) and/or RNaseA (Sigma).
Quantitative RT-PCR
Bone marrow derived macrophages were plated at a density of
26106 per well in 6 well plates and infected with an MOI of 1.
Macrophage RNAwas harvested 4 hours post infection and isolated
with the RNeasy kit (Qiagen) according to the manufacturer’s
protocol. RNA was DNase treated with RQ1 RNase-Free DNase
(Promega) and reverse transcribed with Superscript III (Invitrogen).
Quantitative PCR assays were performed on the Step One Plus RT
PCR System (Applied Biosystems) with Platinum Taq DNA
polymerase (Invitrogen) and EvaGreen dye (Biotium). Gene
expression values were normalized to Rps17 (mouse) or S9 (human)
levels for each sample. The following primer sequences were used:
mouse Ifnb, F, 59-ATAAGCAGCTCCAGCTCCAA-39and R, 59-
CTGTCTGCTGGTGGAGTTCA-39; mouse Rps17, F, 59-CG-
CCATTATCCCCAGCAAG-39 and R, 59- TGTCGGGATC-
CACCTCAATG-39; mouse Rig-i, F, 59-ATTGTCGGCGTCCA-
CAAAG-39 and R, 59-GTGCATCGTTGTATTTCCGCA-39,
human Ifnb, F, 59-AAACTCATGAGCAGTCTGCA-39 and R,
59- AGGAGATCTTCAGTTTCGGAG G-39; human S9, F, 59-
ATCCGCCAGCGCCATA-39 and R, 59-TCAATGTGCTTCT-
GGGAATCC-39.
Cell stimulation and transfection
Cell stimulants were transfected with Lipofectamine 2000
(LF2000, Invitrogen) according to the manufacturer’s protocol.
Nucleic acids were mixed with LF2000 in Optimem (Invitrogen) at
a ratio of 1.0 ml LF2000/mg nucleic acid and incubated for 20
minutes at room temperature. The ligand-lipid complexes were
added to cells at a final concentration of 3.3 mg/ml (96-well plates)
and 1.0 mg/ml (6 well plates). For poly I:C, the stock solution (2.5
mg/ml) was heated at 55uC for 10 minutes and cooled to room
temperature immediately before mixing with LF2000. Transfec-
tion experiments were incubated for 8 hours, unless otherwise
stated. RIG-I, MDA5, TRIF and SdhA expression plasmids, along
with an IFNb-firefly luciferase reporter and TK-Renilla luciferase
plasmids, were transfected with FuGENE 6 (Roche) according to
the manufacturer’s protocol. Nucleic acids were mixed with
FuGENE 6 in Optimem at 0.5 ml/96 well and incubated for 15
minutes. Total transfected DNA was normalized to 200 ng per
well using an empty pcDNA3 plasmid. Cells were stimulated 20
hours after transfection of expression plasmids.
Type I IFN bioassay and luciferase reporter assay
Cell culture supernatants or bronchoalveolar lavage fluid
(BALF) was overlayed on L929-ISRE IFN reporter cells in a 96-
well plate format and incubated for 4 hours at 37uC and 5%CO2.
L929-ISRE IFN reporter cells and HEK293T cells expressing an
IFNb-firefly luciferase reporter and TK-Renilla luciferase were
lysed in Passive Lysis Buffer (Promega) for 5 minutes at room
temperature and relative light units were measured upon injection
of firefly luciferin substrate (Biosynth) or Renilla substrate with the
LmaxII384 luminometer (Molecular Devices). For transient
transfection reporter assays, luciferase values were normalized to
an internal Renilla control.
Cytotoxicity assays
Cytotoxicity of bacterial strains was determined by measuring
lactate dehydrogenase release essentially as previously described
[59]. Macrophages were plated at a density of 16105 in a 96-well
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plate and infected with stationary phase L. pneumophila at a
multiplicity of infection (MOI) of 1. Plates were spun at 4006g for
10 minutes to allow equivalent infectivity of non-motile and motile
strains [12]. Plates were re-spun 4 hours post infection and cell
culture supernatants were assayed for LDH activity. Specific lysis
was calculated as a percentage of detergent lysed cells.
Growth curves
Bacterial growth was determined as previously described [16].
Bone marrow derived macrophages were plated at a density of
16105 per well in white 96-well plates (Nunc) and allowed to
adhere overnight. Macrophages were infected with stationary-
phase L. pneumophila at a multiplicity of infection (MOI) of 0.01.
Growth of luminescent L. pneumophila strains was assessed by RLU
with the LmaxII384 luminometer (Molecular Devices). Nonlumi-
nescent bacterial strains were analyzed for colony-forming units on
buffered charcoal yeast extract plates.
Transposon mutagenesis
Transposon mutagenesis of LP02 was previously described [12].
Briefly, the pSC123 mariner transposon was mated from E.coli
SM10 lpir into the L. pneumophila strain LP02. Matings were
plated on buffered yeast extract charcoal plates with streptomycin
(100 mg/ml) and kanamycin (25 mg/ml). Single colonies were
isolated and grown in overnight cultures and used to infect bone
marrow derived MyD882/2Trif2/2 macrophages. After overnight
incubation, levels of type I interferon in the supernatant was
determined by bioassay. The site of transposon insertion was
determined by Y-linker PCR [60].
In vivo studies
Age and sex-matched Ips-12/2 and littermate Ips-1+/2 mice
were infected intranasally with 2.56106 LP01 DflaA in 20 ml PBS.
Bronchoalveolar lavage was performed 20 hours post infection via
the trachea using a catheter (BD Angiocath 18 g, 1.3648 mm)
and 800 ml PBS. Type I interferon induction was determined by
bioassay. Type I interferon amounts were calculated using a 4-
parameter standard curve determined by dilution of recombinant
IFNb (R&D Systems). CFUs were determined by hypotonic lysis
of cells from the brochoalveolar lavage fluid (BALF). In parallel
experiments, it was determined that CFU in the BALF was
representative of total CFU in the lung.
shRNA knockdown
Knockdown constructs were generated with the MSCV/
LTRmiR30-PIG (LMP) vector from Open Biosystems. shRNA
PCR products were cloned into the LMP vector using XhoI and
EcoRI sites. Rig-i sequence: 59-GCCCATTGAAACCAAGAA-
ATT-39, control shRNA sequence: 59-TGACAGTGTCTTCGC-
TAATGAA-39. MyD882/2Trif2/2 immortalized bone marrow
derived macrophages were transduced with retrovirus as previ-
ously described [10]. GFP+ macrophages were sorted with the
DAKO-Cytomation MoFlo High Speed Sorter.
Supporting Information
Figure S1 L. pneumophila replication is restricted in Ips-12/2 and
Mda-52/2 macrophages. Ips-1+/2, Ips-12/2, C57BL/6 (B6) and
Mda52/2 macrophages were infected at an MOI of 0.01 and
growth of luminescent L. pneumophila strains was determined by
RLU at 0, 24, 48, and 72 hours post infection. (A) Ips-1+/2 and
Ips-12/2 macrophages were infected WT (LP02) L. pneumophila (B)
C57BL/6 (B6) and Mda52/2 macrophages were infected as in A
(C) Ips-1+/2 and Ips-12/2 macrophages were infected with Ddot L.
pneumophila (D) C57BL/6 (B6) and Mda52/2 macrophages were
infected as in C (E) Ips-1+/2 and Ips-12/2 infected with DflaA L.
pneumophila (F) C57BL/6 (B6) and Mda52/2 macrophages were
infected as in E.
Found at: doi:10.1371/journal.ppat.1000665.s001 (0.31 MB PDF)
Figure S2 Abrogation of type I interferon receptor signaling
alone does not permit growth of DsdhA mutant. C57BL/6 (B6) and
Ifnar2/2 macrophages were infected at an MOI of 0.01 and
growth of luminescent L. pneumophila strains was determined by
RLU at 0, 24, 48, and 72 hours post infection. (A) C57BL/6 (B6)
and Ifnar2/2 macrophages were infected WT (LP02) L. pneumophila
(B) macrophages were infected as in A but with DsdhA L.
pneumophila (C) DflaA L. pneumophila (D) DflaADsdhA L. pneumophila
(E) Ddot L. pneumophila.
Found at: doi:10.1371/journal.ppat.1000665.s002 (0.29 MB PDF)
Figure S3 SdhA represses MDA5 and RIG-I induction of
interferon. Overexpression of SdhA in HEK293T cells results in
repression of interferon induction mediated by MDA5 or RIG-I
but not TRIF. (A) HEK293T cells were transfected with plasmids
encoding the IFNb-firefly luciferase reporter, TK-Renilla luciferase
reporter (for normalization), full length MDA5 and/or increasing
amounts of full length SdhA. At 20 hours post transfection, cells
were transfected with poly I:C and then firefly luciferase and
Renilla luciferase levels were determined 8 hours later. (B)
Transfection and stimulation were performed as in A, except
with a RIG-I expression plasmid and/or increasing amounts of full
length SdhA expression plasmid. (C) Transfection and stimulation
were performed as in A, except with a Trif expression plasmid
and/or SdhA.
Found at: doi:10.1371/journal.ppat.1000665.s003 (0.27 MB PDF)
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